Task: Answer the multiple-choice question.
Question: Which compound exhibits a 2.349\% human ether-à-go-go related gene (hERG) inhibition at 1uM?
Constraint: You must select none, one or more options from a or b without using any additional words.
Options:
(a) Cc1cc(NC(=O)C23CC4CC(CC(C4)C2)C3)n[nH]1
(b) CN(CC(=O)Nc1cccc(F)c1)C(=O)CCNC(=O)c1ccc(Br)cc1
Answer: b. CN(CC(=O)Nc1cccc(F)c1)C(=O)CCNC(=O)c1ccc(Br)cc1
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_1uM#}{herg_central_at_1uM__units} {herg_central_at_1uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_1uM%}
Answer: {%multiple_choice_result}. {SMILES#}
CN(CC(=O)Nc1cccc(F)c1)C(=O)CCNC(=O)c1ccc(Br)cc1
CN(CC(=O)Nc1cccc(F)c1)C(=O)CCNC(=O)c1ccc(Br)cc1
4-bromo-N-[3-[[2-(3-fluoroanilino)-2-oxoethyl]-methylamino]-3-oxopropyl]benzamide